These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19075685)

  • 21. Cell engineering and cultivation of chinese hamster ovary (CHO) cells.
    Omasa T; Onitsuka M; Kim WD
    Curr Pharm Biotechnol; 2010 Apr; 11(3):233-40. PubMed ID: 20210750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.
    Grillberger L; Kreil TR; Nasr S; Reiter M
    Biotechnol J; 2009 Feb; 4(2):186-201. PubMed ID: 19226552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and refolding technologies for production of recombinant proteins.
    Arakawa T
    Curr Pharm Biotechnol; 2010 Apr; 11(3):231-2. PubMed ID: 20406165
    [No Abstract]   [Full Text] [Related]  

  • 24. 9th International drug delivery technologies & deal-making summit.
    Panzner S; Smith PL
    Expert Opin Drug Deliv; 2005 Jan; 2(1):189-90. PubMed ID: 16296745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines to cell engineering for monoclonal antibody production.
    Rita Costa A; Elisa Rodrigues M; Henriques M; Azeredo J; Oliveira R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):127-38. PubMed ID: 19853660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in solid dosage form manufacturing technology.
    Andrews GP
    Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2935-49. PubMed ID: 17855217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 28. Negative design for improved therapeutic proteins.
    Desjarlais JR; Lazar GA
    Trends Biotechnol; 2003 Oct; 21(10):425-7. PubMed ID: 14512227
    [No Abstract]   [Full Text] [Related]  

  • 29. Venturing into drug discovery.
    Steinmetz M
    Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody Engineering & Design 2010. 24-25 February 2010, Frankfurt, Germany.
    Beck A
    IDrugs; 2010 May; 13(5):295-9. PubMed ID: 20432182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulatory consequences for the use of monoclonal antibodies].
    Lackner F; Behr-Gross ME
    Med Sci (Paris); 2009 Dec; 25(12):1183-8. PubMed ID: 20035703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monoclonal antibodies, 30 years of success].
    Laffly E; Sodoyer R
    J Soc Biol; 2006; 200(4):325-43. PubMed ID: 17652969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant polyclonal antibodies: the next generation of antibody therapeutics?
    Haurum JS
    Drug Discov Today; 2006 Jul; 11(13-14):655-60. PubMed ID: 16793535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunobiological aspects of therapeutic antibodies and related characterization approaches.
    Liu PM; Handl H; Zou L; Kim B
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):515-22. PubMed ID: 17786849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development.
    Mould DR; Sweeney KR
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):84-96. PubMed ID: 17265746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Data warehousing.
    Derendorf H
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):S1-2. PubMed ID: 11911605
    [No Abstract]   [Full Text] [Related]  

  • 40. Innovative and economic potential of mammalian cell culture.
    Werner RG
    Arzneimittelforschung; 1998 Apr; 48(4):423-6. PubMed ID: 9608886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.